Home
>
National Drug Code (NDC)
>
REMERONSOLTAB
REMERONSOLTAB - 0052-0106-30 - (MIRTAZAPINE)
Drug Information of REMERONSOLTAB
| Product NDC: | 0052-0106 |
| Proprietary Name: | REMERONSOLTAB |
| Non Proprietary Name: | MIRTAZAPINE |
| Active Ingredient(s): | 15 mg/1 & nbsp; MIRTAZAPINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REMERONSOLTAB
| Product NDC: | 0052-0106 |
| Labeler Name: | Organon Pharmaceuticals USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021208 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010112 |
Package Information of REMERONSOLTAB
| Package NDC: | 0052-0106-30 |
| Package Description: | 5 BLISTER PACK in 1 BOX (0052-0106-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0052-0106-06) |
NDC Information of REMERONSOLTAB
| NDC Code | 0052-0106-30 |
| Proprietary Name | REMERONSOLTAB |
| Package Description | 5 BLISTER PACK in 1 BOX (0052-0106-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0052-0106-06) |
| Product NDC | 0052-0106 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MIRTAZAPINE |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20010112 |
| Marketing Category Name | NDA |
| Labeler Name | Organon Pharmaceuticals USA |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
